Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole Duration for GI Injury Prevention in Post-CABG DAPT
NCT03908593Phase 4Unknown
- Sponsor
- Ruijin Hospital
- Start
- Oct 2019
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pantoprazole in gastrointestinal mucosal injury, sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
pantoprazole
03
Conditions
gastrointestinal mucosal injury
Beyond the preview
Go deeper on NCT03908593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03908593.